About Thomas Shehab
Thomas Shehab is a gastroenterologist and managing partner at Arboretum Ventures. He is also an Endogenex director. Endogenex is evaluating an endoscopic pulsed-electric-field system for people with type 2 diabetes.
A 2024 Avation Medical release identified him as its board chair. Avation was launching Vivally, a prescription wearable neuromodulation system for bladder treatment.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Thomas Shehab in the role, so the role may have started earlier or lasted longer.
Endogenex, Inc. Current
Managing Partner and director
2026 – Present · Plymouth, MN
Endogenex develops an outpatient endoscopic system using pulsed electric fields to treat duodenal tissue in adults with type 2 diabetes.
AV
Arboretum Ventures Current
Managing Partner
AM
Avation Medical Current
board chair
Virtual Incision Corp
Director
2025 · Lincoln, NE
Miniature robotic surgery systems for surgeons and healthcare facilities.
Sonarmd, Inc.
Director
2020 – 2024 · Chicago, IL
Monitors digestive disease symptoms between visits for patients and their care teams.
Key Colleagues at Startups
The people Thomas Shehab works with at each company, as listed on that company's latest Form D.
Endogenex, Inc. · Form D/A, Nov 6, 2026
Stacey Pugh
CEO and director
Juliet Bakker
Co-Founder and Managing Director
GB
Gerald Brunk
Managing Director
JE
James Eadie
Managing Director
DR
Doug Reed
Director
Virtual Incision Corp · Form D/A, May 6, 2025
FR
Fred Robertson
Director
TL
Tao Lin
Director
JM
John Murphy
Executive officer and director
FP
Fernando Pacheco
Director
MS
Mukund Srinivasan
Chief Financial Officer
TS
Tyler Stowater
Director
Sonarmd, Inc. · Form D, Jul 17, 2024
LK
Lawrence Kosinski
FOUNDER and BOARD MEMBER
BH
Beth Houck
Chief Executive Officer and director
Roy Beveridge
Board Member
Charity Tarn
Board Member
Motif Neurotech, Inc. · Form D, Jan 24, 2024
